Fitch revises National Jewish Health’s outlook to positive

Fitch Ratings has affirmed its “BB+” rating on Denver-based National Jewish Health’s following bonds, issued by the Colorado Health Facilities Authority:

Advertisement

  • $21.1 million of series 2012 fixed rate bonds
  • $10.3 million of series 2005 variable rate demand bonds

Moody’s revised the outlook to positive from stable.

The outlook revision is based on several factors, including NJH’s dramatically improved operating profitability and leveraging of its specialized services such as pulmonary disease treatment.

More articles on healthcare finance:
Rural vs. urban: A comparison of hospital costs and charges
OIG tags shuttered Louisiana hospital for incorrect billing
SwervePay raises $10M for texting-based patient payment platform

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.